(19)
(11) EP 3 860 567 A1

(12)

(43) Date of publication:
11.08.2021 Bulletin 2021/32

(21) Application number: 19869416.8

(22) Date of filing: 27.09.2019
(51) International Patent Classification (IPC): 
A61K 9/00(2006.01)
A61K 9/16(2006.01)
A61K 39/00(2006.01)
A61K 47/00(2006.01)
A61K 9/08(2006.01)
A61K 9/19(2006.01)
A61K 39/395(2006.01)
(86) International application number:
PCT/US2019/053462
(87) International publication number:
WO 2020/072306 (09.04.2020 Gazette 2020/15)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 01.10.2018 US 201862739542 P

(71) Applicant: Amgen Inc.
Thousand Oaks, California 91320 (US)

(72) Inventors:
  • JAGANNATHAN, Bharadwaj
    Thousand Oaks, California 91320-1799 (US)
  • HUH, Joon
    Thousand Oaks, California 91320-1799 (US)
  • TREUHEIT, Michael
    Thousand Oaks, California 91320-1799 (US)
  • SHAN, Daxian
    Thousand Oaks, California 91320-1799 (US)

(74) Representative: J A Kemp LLP 
14 South Square Gray's Inn
London WC1R 5JJ
London WC1R 5JJ (GB)

   


(54) METHODS FOR REDUCING AGGREGATION OF BISPECIFIC ANTIBODIES